# Transient regulatory T cell manipulation is limited by anti-antibody responses in HIV-1 envelope immunized rhesus macaques

**Authors:** Shuqin Gu, Kan Luo, Tarra A. Von Holle, Thaddeus C. Gurley, Hilary Bouton-Verville, Laura L. Sutherland, Robert Parks, Xiaoying Shen, Rachel L. Spreng, Georgia D. Tomaras, David C. Montefiori, Hua-Xin Liao, Barton F. Haynes, M. Anthony Moody

PMC · DOI: 10.1016/j.isci.2025.113191 · 2025-07-23

## TL;DR

Disrupting regulatory T cells in monkeys with HIV vaccines briefly changes immune responses but is limited by immune reactions to the treatment itself.

## Contribution

Demonstrates that anti-CD25 treatment transiently affects Treg cells but is limited by anti-drug antibodies in HIV-vaccinated monkeys.

## Key findings

- Anti-CD25 treatment reduces Treg and follicular Treg cell frequency after the first infusion.
- Treg disruption modifies germinal center responses but does not improve antibody breadth.
- Anti-drug antibodies develop in treated monkeys, limiting the effectiveness of subsequent infusions.

## Abstract

CD25+ FoxP3+ CD4+ regulatory T (Treg) cells promote immune tolerance. We studied germinal center responses and HIV-1 antibody development in rhesus macaques (RMs) immunized with sequential CH505 gp120 envelopes (Envs), with or without anti-CD25 monoclonal antibody (mAb). Plasma Env antibody levels and CD4 binding sited-directed responses were similar across groups. Treg and CXCR5-expressing follicular Treg cell frequency dropped more than two times after the first anti-CD25 infusion but not later ones. Transient Treg disruption was associated with a reduced proportion of vaccine-elicited B cell clonal lineages in lymphoid tissue, but did not result in neutralization breadth. Anti-CD25-treated RMs developed anti-drug antibodies, correlating with reduced plasma mAb levels after subsequent infusions. Germinal center responses were modified by Treg perturbation intended to induce HIV-1 bnAbs, but this effect was curtailed by anti-antibody responses. This may have implications for vaccination in persons receiving immune modulating drugs for transplants or other medical conditions.

•Anti-CD25 treatment briefly perturbs Treg cell frequency in HIV Env-immunized rhesus macaques•Treg disruption alters germinal center responses but does not enhance antibody breadth•Anti-CD25-induced Treg perturbation is constrained by anti-drug immune responses

Anti-CD25 treatment briefly perturbs Treg cell frequency in HIV Env-immunized rhesus macaques

Treg disruption alters germinal center responses but does not enhance antibody breadth

Anti-CD25-induced Treg perturbation is constrained by anti-drug immune responses

Biological sciences; Immunology; Virology

## Linked entities

- **Proteins:** IL2RA (interleukin 2 receptor subunit alpha), FOXP3 (forkhead box P3), CD4 (CD4 molecule), CXCR5 (C-X-C motif chemokine receptor 5)

## Full-text entities

- **Genes:** FOXP3 (forkhead box P3) [NCBI Gene 574303], CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 701792] {aka BLR1}, CD4 (CD4 molecule) [NCBI Gene 713807]
- **Species:** Macaca mulatta (rhesus macaque, species) [taxon 9544], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12355595/full.md

---
Source: https://tomesphere.com/paper/PMC12355595